Image

Clinical Feasibility of the IMES Transradial Prosthesis

Clinical Feasibility of the IMES Transradial Prosthesis

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This study will evaluate the feasibility of using implanted myoelectric sensors (IMES) to control a transradial prosthesis

Description

The study assesses the feasibility of an implantable myoelectric prosthesis control system to control a transradial prosthesis. Implantable Myoelectric Sensors (IMES) will be implanted into the residual forearm muscles of three transradial amputee subjects. These devices wirelessly transmit electrical muscle signals to an electromechanical prosthetic wrist and hand.

Following a two-week recovery from implantation of up to 16 IMES into residual forearm muscles, subjects will begin a two week training phase. When they receive their custom-fit IMES Transradial Prosthesis (including electromechanical wrist and hand) subjects initiate approximately four months of home use. Subjects will be offered up to five post-study follow-up visits. The usability and functionality of the prosthetic system will be evaluated throughout the study.

Eligibility

Inclusion Criteria:

  • (unilateral acquired transradial) amputation
  • residual limb size requirements to fit investigational device componentry
  • at least 6 residual muscle locations available for implantation
  • good compliance with health service (rehabilitation)
  • willing to undergo surgical implantation of IMES Sensor implants
  • experience with myoelectric upper limb prostheses
  • using own myoelectric device approximately 6-8h/day
  • able to provide informed consent and attend the study visits

Exclusion Criteria:

  • any condition which in the opinion of the investigator poses a risk to health
  • neurological disorder that may prohibit accurate control
  • major injury proximal to the level of amputation
  • neuromuscular disorder
  • nerve transection or palsy that may cause de-innervation of muscles planned for implantation
  • allergy to implanted materials
  • existing active implant

Study details
    Amputation

NCT04936789

Össur Iceland ehf

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.